Hi,
1.ScFv therapy serves as a powerful and potential therapeu-tic tool in neurodegenerative diseases that are particularly associated with the accumulation of misfolded protein ag-gregates, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD)
2.sin-gle-chain fragment variable antibodies (scFvs) to target the pathological protein aggregates, such as amyloid-beta (Aβ) peptides, α-synuclein (α-syn) and Huntingtin (Htt).
3.Pros of scFvs
a.)maintain the antigen-binding activity, affinity and specificity of full-sized antibodies.
b)Since scFv is smaller in size, it permits better penetra-tion for tissues that are hardly or inaccessible to conventional monoclonal antibodies .
c.)it can de-grade easily in human body, which leads to shorter half-lives and promotes rapid elimination from bloodstream
d)scFvs which lack FC fragment also show minimised immunogenicity as a cellular immune response is commonly triggered by the binding of FC region to the com-plement proteins .
4.ScFvs therapy in-
a. Parkinson- The use of scFvs in preventing α-synuclein accumulation has emerged as an immunotherapy strategy against PD.
D5- Target-in vitro SDS generated dimeric and tetrameric α-syn
Findings-Eliminates the toxicity and aggregates of oligomeric α-syn present in post-mortem human PD brain tissue and CSF samples
D10- Target-Human monomeric wild- type α-syn
Findings-Stabilizes detergent- soluble monomeric α-syn
b.Alzheimer:scFv has been designed to target amyloid-β peptide aggregation.
antibody-
Phage-displayed b4.4
Findings-
neutralizes the toxicity of Aβ-derived diffusible ligands (ADDLs) in SH-SY5Y cell line .
C.Huntington's :he use of scFv, which binds to specific epitopes of hu-man huntingtin, could reduce the aggregation, hence it has the potential to decrease the cytotoxicity of mutant Htt and the misfolded huntingtin, in turns delay the progression of HD. .
Target:17 N-terminal Htt
Antibody:Phage displayed C4
Findings:Reduces expanded huntingtin fragments in organotypic slice cul-tures of the cortico-striatum .
Conculsion:ScFv is a valuable intrabody technology that is used to study a wide range of neurological disorders because increasing evidence has demonstrated that scFv is highly specific in targeting against abnormal protein aggregate
Thanks for reading this post. Keep sharing.
Comments
Post a Comment